InvestorsHub Logo
Followers 112
Posts 8606
Boards Moderated 0
Alias Born 02/27/2016

Re: MI Dendream post# 402153

Wednesday, 09/15/2021 8:43:34 AM

Wednesday, September 15, 2021 8:43:34 AM

Post# of 704229

ae kusterer Wednesday, 09/15/21 08:36:45 AM
Re: None 0
Post #
402167
of 402172

Linda Liau speaks 10/17 at 12/45 p.m. at CNS. Is she booked for any other presentations in September, October, or Novemebr, '21?



https://2021meeting.cns.org/Assets/edccc356-3f88-4c09-ba3f-b101e0a28585/637636915731000000/cns21787-21am-prelim-05242021-copy-with-4-new-gss-pages-080421-3-pm-pdf?inline=ture



NEW! 12:45–4:15 pm
SYM20B: Immunotherapy for Brain Tumors: New
Concepts
Course Directors: E. Antonio Chiocca, Linda M. Liau
Faculty: Nduka M. Amankulor, William T. Curry, Peter E.
Fecci, Amy B. Heimberger, Michael Lim, Edjah K. Nduom,
Hideho Okada, Ian F. Parney
Course Description: This symposium will provide a brief
overview of relevant immunological principles and define
discrete immune pathways regulating the initiation and
progression of malignant brain tumors. More importantly,
cutting-edge immunotherapeutic approaches for the
treatment of CNS tumors will be defined.
Learning Objectives:
? Evaluate various immune pathways that contribute to the
formation and progression of CNS malignancies
? Compare different immunotherapeutic strategies,
including virotherapy, adoptive cellular immunotherapy,
and immune checkpoint inhibition
? Compare neoadjuvant and adjuvant immunotherapy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News